GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS

Clinical trials for GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS explained in plain language.

Never miss a new study

Get alerted when new GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS trials appear

Sign up with your email to follow new studies for GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a One-Year bone drug switch beat standard therapy for Steroid-Induced bone loss?

Disease control Not yet recruiting

This study follows people with bone loss caused by long-term steroid use to compare two treatment approaches. One group received romosozumab for the first year and then switched to denosumab, while the other group took denosumab throughout. After six years, researchers will measu…

Matched conditions: GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS

Phase: PHASE4 • Sponsor: Tuen Mun Hospital • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC

GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS

Get alerted when new GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS trials appear

Can a One-Year bone drug switch beat standard therapy for Steroid-Induced bone loss?